When was Kaster founded?

Kaster was founded in 2022 and raised its 1st funding round 4 years after it was founded.

Where is Kaster located?

Kaster is headquartered in Montreal, Canada.

How many employees does Kaster have?

As of Sep 30, 2026, the latest employee count at Kaster is 13.

Is Kaster a funded company?

Kaster is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Feb 09, 2026.

When was the latest funding round of Kaster?

Kaster's latest funding was a $***** Seed round on Feb 09, 2026, with participation from 2 investors.

Where does Kaster rank among its competitors?

Kaster ranks 8th amongst 30 active competitors, of which 9 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was CellsBin, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of Kaster?

Kaster's top competitors include Promise, Etcembly and OncoImmunity. Among them, CellsBin secured the most recent funding round in September, 2026.

Kaster - 2026 Company Profile, Funding & Competitors

Kaster is a seed company based in Montreal (Canada), founded in 2022. It operates as a Developer of short-term production planning software for pharmaceutical manufacturers. Kaster has raised $1.17M in funding from Graphite Ventures. The company has 30 active competitors, including 9 funded and 1 that has exited. Its top competitors include companies like Promise, Etcembly and OncoImmunity.

Company Details

Developer of short-term production planning software for pharmaceutical manufacturers. The software aims to restore stability and on-time performance across shared resources. It synchronizes planning, cleanrooms, and support teams in real time. The software removes recurring slowdowns and improves flow across production stages. It enables proactive, data-driven actions instead of reactive firefighting. The software automatically respects rules, equipment constraints, and timing requirements. It continuously adjusts production plans down to the minute.

Key Metrics

Founded Year

2022

Location

Montreal, Canada

Stage

Seed

Total Funding

$1.17M in 1 round

Latest Funding Round

Seed, Feb 09, 2026, $*****

Investors

Graphite Ventures & 1 more

Ranked

8^th among 30 active competitors

Employee Count

13 as on Sep 30, 2026

Similar Companies

Promise & 25 more

View Kaster's full profile

Kaster has raised a total funding of $1.17M over 1 round. Its latest funding round was a Seed round on Feb 09, 2026 for $*****. 2 investors participated in its latest round. Kaster has 2 institutional investors.

Here is the list of recent funding rounds of Kaster:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 09, 2026	9862546	Seed	9372640	1702585	4182754	5684382

Access funding benchmarks and valuations. Sign up today!

View details of Kaster's funding rounds and investors

Kaster's employee count trend

Kaster has 13 employees as of Sep 26. Here is Kaster's employee count trend over the years:

Uncover Kaster's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kaster include Promise, Etcembly and OncoImmunity. Here is the list of Top 10 competitors of Kaster, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Promise 2020, Tel Aviv (Israel), Seed	Provider of AI-based platform for personalised treatment plans	$8.3M	Awz Ventures, Pfizer & 2 others	56/100
2nd	Etcembly 2020, Harwell (United Kingdom), Series A	Developer of AI-driven technology for engineering and designing novel immunotherapies	$12.7M	-	54/100
3rd	OncoImmunity 2014, Oslo (Norway), Acquired	Developer of machine-learning based software for personalized cancer immunotherapy	$7.37M	EIC Fund, Radforsk & 2 others	47/100
4th	Apriori Bio 2020, Belmont (United States), Seed	AI-based infection control and vaccine prediction tool for healthcare	$1.1M	CEPI, Flagship Pioneering	46/100
5th	Archon Bio 2023, Seattle (United States), Seed	Provider of computational platform to develop protein therapeutics	$20M	Madrona, Washington Research Foundation & 5 others	45/100
6th	Inceptive 2021, Palo Alto (United States), Series A	AI-based RNA molecular modeling tool for the vaccine	$120M	Nvidia, Andreessen Horowitz & 4 others	43/100
7th	CellsBin 2022, New Haven (United States), Series A	Developer of nanophotonic platforms for detecting and isolating rare cells	-	108 BioCapital, Connecticut Innovations	38/100
8th	Kaster 2022, Montreal (Canada), Seed	Developer of short-term production planning software for pharmaceutical manufacturers	$1.17M	Graphite Ventures, Hidden Layers	29/100
9th	SQALE 2023, Copenhagen (Denmark), Funding Raised	Provider of bioprocess optimization services for microalgae and precision fermentation companies	-	BioInnovation Institute	28/100
10th	Numerion 2012, San Francisco (United States), Series B	Developer of an AI platform for discovering novel drug-like molecules	$19.8M	-	27/100